Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Dermatologic 1

Conditions

Lymphoma 217Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Lymphoma, Large B-Cell, Diffuse 173Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 90Leukemia 80Lymphoma, Follicular 79Lymphoma, Mantle-Cell 53Hodgkin Disease 46Lymphoma, B-Cell 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Lymphoma, Large-Cell, Anaplastic 29Lymphoma, T-Cell, Peripheral 28Lymphoma, Large-Cell, Immunoblastic 27Recurrence 24Lymphoma, B-Cell, Marginal Zone 22Leukemia, Lymphocytic, Chronic, B-Cell 21Lymphoma, T-Cell 17Leukemia, Biphenotypic, Acute 17Dendritic Cell Sarcoma, Interdigitating 17Immunoblastic Lymphadenopathy 16Neoplasms 14Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11HIV Infections 10Waldenstrom Macroglobulinemia 7Enteropathy-Associated T-Cell Lymphoma 7Blast Crisis 7Multiple Myeloma 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, AIDS-Related 6

Interventions

Rituximab 17Peripheral Blood Stem Cell Transplantation 15Cyclophosphamide 15fludarabine phosphate 12Whole-Body Irradiation 11Cyclosporine 10Mycophenolic Acid 9Etoposide 9Methotrexate 8Filgrastim 8Lenalidomide 7Tacrolimus 6Dexamethasone 6Busulfan 6Radiotherapy 5Melphalan 5Cytarabine 5Carboplatin 5Vorinostat 4Thiotepa 4Therapeutics 4Psychiatric Rehabilitation 4Bortezomib 4Antilymphocyte Serum 4Transplantation 3Methylprednisolone 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3Flow Cytometry 3Dasatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Intraocular Lymphoma × Vincristine × Lymphoid × Clear all
NCT02213913 2026-03-11

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

University of Chicago

Phase 1/2 Completed
55 enrolled 17 charts
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Intraocular Lymphoma

NCT00933985 2014-05-01

Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia

National Cancer Institute (NCI)

Phase 1 Terminated
22 enrolled
DermatologicLymphoidOther hematologic neoplasmSarcoma

Blast Crisis, Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Mycosis Fungoides, Recurrence, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡